Get started
Author

Yoko Nawata

Observed names: *Yoko Nawata, Y Nawata, Y. Nawata, 縄田陽子, 陽子 縄田
OpenAlex ID: A5073736900
Suppression of methamphetamine-seeking behavior by nicotinic agonists
2006 · Takato Hiranita, Yoko Nawata, et al. · Proceedings of the National Academy of Sciences · 91
Increases of CRF in the amygdala are responsible for reinstatement of methamphetamine-seeking behavior induced by footshock
2012 · Yoko Nawata, Kiyoyuki Kitaichi, et al. · Pharmacology Biochemistry and Behavior · 47
A Cannabinoid CB1 Receptor Antagonist Ameliorates Impairment of Recognition Memory on Withdrawal from MDMA (Ecstasy)
2009 · Yoko Nawata, Takato Hiranita, et al. · Neuropsychopharmacology · 31
Methamphetamine-seeking behavior is due to inhibition of nicotinic cholinergic transmission by activation of cannabinoid CB1 receptors
2008 · Takato Hiranita, Yoko Nawata, et al. · Neuropharmacology · 26
Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats
2018 · Yoko Nawata, Taku Yamaguchi, et al. · The International Journal of Neuropsychopharmacology · 22
Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251
2015 · Yoko Nawata, Kiyoyuki Kitaichi, et al. · Drug and Alcohol Dependence · 12
A tryptamine-derived catecholaminergic enhancer, (−)-1-(benzofuran-2-yl)-2-propylaminopentane [(−)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats
2009 · T. Hiranita, T. Yamamoto, et al. · Neuroscience · 7
Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)
2023 · Yoko Nawata, Rina Ooishi, et al. · Behavioural Brain Research · 4
Autistic-like Behaviors Mediated by the Dysregulation of Endocrine Systems Via Oxytocin and Corticosterone in Cannabinoid Cb1 Receptor Knockout Mice
2025 · *Yoko Nawata, Tsuyoshi Nishioku, et al. · The International Journal of Neuropsychopharmacology · 2
PDF
3,4-Methylenedioxymethamphetamine (MDMA) impairs cognitive function during withdrawal via activation of the arachidonic acid cascade in the hippocampus
2024 · Yoko Nawata, Tsuyoshi Nishioku, et al. · Drug and Alcohol Dependence · 2
[Drug self-administration methods to the study of drug craving (drug seeking behavior)].
2008 · Yoko Nawata, Tsuneyuki Yamamoto · PubMed · 1
LIT-001, a non-peptide oxytocin receptor agonist, ameliorates autistic-like behaviors in cannabinoid CB1 receptor knockout mice
2023 · Yoko Nawata, Tsuyoshi Nishioku, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
A cannabinoid CB1 receptor knockout mouse demonstrates autism spectrum disorder-like behaviors
2022 · Yoko Nawata, Mika Azukuri, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Low serum oxytocin levels and autism spectrum disorder-like behaviors in mice lacking the cannabinoid CB1 receptors
2022 · Yoko Nawata, Mika Azukuri, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Bidirectional regulation by the endocannabinoid in retrieval of fear memory using the fear conditioning task in mice
2021 · Yoko Nawata, Asami Ueno, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
The monoacylglycerol lipase inhibitor JZL184 attenuates methamphetamine-seeking behaviors in methamphetamine self-administered rats
2020 · Yoko Nawata, Taku Yamaguchi, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Ameliorating effects of monoacylglycerol lipase inhibitor via cannabinoid CB 1 receptors on the cue-induced reinstatement of methamphetamine-seeking and anxiety-like behaviors in methamphetamine self-administered rats
2019 · Yoko Nawata · Asian College of Neuropsychopharmacology
依存性薬物の探索行動(渇望)におけるカンナビノイドcb 1 受容体-アラキドン酸カスケードの役割
2013 · Yamaguchi Taku, Yoko Nawata, et al.
[JSNP Excellent Presentation Award for AsCNP 2011: improvement of cognitive impairments on withdrawal after repeated methamphetamine by administration of a cannabinoid CB1 receptor antagonist and a COX inhibitor].
2012 · Y Nawata, T Yamaguchi, et al. · PubMed
覚せい剤メタンフェタミン退薬時に認められる認知機能障害に対するカンナビノイドcb 1 受容体拮抗薬ならびにcox阻害薬による改善
2012 · 縄田陽子, 山口拓, et al.
[Stimulative role of corticotropin-releasing factor in methamphetamine-seeking behavior induced by footshock].
2011 · Yoko Nawata, Kiyosachi Kitaichi, et al. · PubMed
恐怖記憶の消去を司るエンドカンナビノイド : Ptsd治療への可能性(g・医薬化学)
2010 · 陽子 縄田 · ファルマシア
大脳基底核と報酬効果--ドパミン神経伝達の観点から (特集 大脳基底核と情動) -- (基底核と高次機能)
2008 · 経之 山本, 陽子 縄田 · 分子精神医学
依存性薬物としてのmdmaの臨床ならびに行動薬理学的特徴 (あゆみ 薬物依存の神経科学--違法ドラッグと覚せい剤による神経精神毒性)
2006 · 陽子 縄田, 経之 山本 · 医学のあゆみ
Hippocampal nicotinic activation ameliorates methamphetamine-seeking
2005 · 平仁田 尊人, Takato Hiranita, et al. · Nihon shinkei seishin yakurigaku zasshi
Works count: 25
Citation count: 245
H-index: 7
I10-index: 6
Year
Topic
Type